To catch up on all of the news from this past week, listen to our weekly news brief for the week of April 13–17, 2026.
This week’s brief covers updates to NCCN Guidelines for early breast cancer screening driven by AI-identified high risk, a multiagent system for oncology clinical trial matching, and a review of AI systems’ performance with or without dermatologists for detecting melanoma.
To learn more about the NCCN Guidelines updates, read "NCCN Guidelines Update Recommends Breast Cancer Screening at Age 35 for High-Risk Women Identified by AI," or see the updated NCCN Guidelines.
For more information on a system for oncology clinical trial matching, read "Neurosymbolic, Multiagent AI Speeds Oncology Clinical Trial Matching by Fourfold," or see the source report in ESMO Real World Data and Digital Oncology.
To learn more about the melanoma detection review, read "Comparable Melanoma Detection for AI vs Dermatologists, Systemic Review Shows," or see the source report in JAMA Dermatology.
Disclaimer: This newscast was generated with the assistance of AI tools and avatars. All content is reviewed and approved by the editorial staff of ASCO AI in Oncology. Contact us with any questions.
The ideas and opinions expressed in ASCO AI in Oncology do not necessarily reflect those of Conexiant or ASCO. The mention of any company, product, service, or therapy should not be construed as an endorsement of any kind. Conexiant and ASCO assume no responsibility for any injury or damage to persons or property arising out of or related to any use of material contained in this publication or to any errors or omissions.